Appropriate referral to a specialty sickle cell clinic for education, genetic counselling, and routine follow-up care is essential and should occur as soon as diagnosis is made.
Initial education for parents and carers should include the importance of:[150]Yates AM, Aygun B, Nuss R, et al. Health supervision for children and adolescents with sickle cell disease: clinical report. Pediatrics. 2024 Aug 1;154(2):e2024066842.
https://publications.aap.org/pediatrics/article/154/2/e2024066842/197803/Health-Supervision-for-Children-and-Adolescents?autologincheck=redirected
http://www.ncbi.nlm.nih.gov/pubmed/39034826?tool=bestpractice.com
attending regular healthcare appointments, and
having antibiotic prophylaxis and immunisations, as recommended.
Offer education to parents and carers about signs and symptoms of the disease's complications, prevention techniques, and treatment options.[37]Asnani MR, Quimby KR, Bennett NR, et al. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications. Cochrane Database Syst Rev. 2016 Oct 6;(10):CD011175.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011175.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/27711980?tool=bestpractice.com
Give instructions on abdominal palpation and measurement to look for an enlarged spleen and the need for urgent medical attention if this is discovered.
Discuss management of dactylitis and other painful complications.[150]Yates AM, Aygun B, Nuss R, et al. Health supervision for children and adolescents with sickle cell disease: clinical report. Pediatrics. 2024 Aug 1;154(2):e2024066842.
https://publications.aap.org/pediatrics/article/154/2/e2024066842/197803/Health-Supervision-for-Children-and-Adolescents?autologincheck=redirected
http://www.ncbi.nlm.nih.gov/pubmed/39034826?tool=bestpractice.com
Inform parents and carers that urgent medical attention is required if the child develops any of:
Fever
Pallor of the skin, lips, or nail beds
Respiratory symptoms
Signs of pain or inability to move extremities
Early signs of splenic sequestration, including pallor and listlessness
Advise parents and carers on maintaining adequate hydration and a healthy diet, preventing infections (including vaccinations), and avoiding factors that may trigger a crisis.
Discuss symptoms of the later stages, and complications affecting older children and adults with patients and parents, including stroke, enuresis, priapism, cholelithiasis, delayed puberty, proliferative retinopathy, avascular necrosis of the hip or shoulder, and leg ulcers.[150]Yates AM, Aygun B, Nuss R, et al. Health supervision for children and adolescents with sickle cell disease: clinical report. Pediatrics. 2024 Aug 1;154(2):e2024066842.
https://publications.aap.org/pediatrics/article/154/2/e2024066842/197803/Health-Supervision-for-Children-and-Adolescents?autologincheck=redirected
http://www.ncbi.nlm.nih.gov/pubmed/39034826?tool=bestpractice.com
Give adolescent and adult patients information about issues related to contraception, carrier testing of partners, genetic counselling, and antenatal diagnosis. Contraception is recommended to prevent unwanted pregnancies.[150]Yates AM, Aygun B, Nuss R, et al. Health supervision for children and adolescents with sickle cell disease: clinical report. Pediatrics. 2024 Aug 1;154(2):e2024066842.
https://publications.aap.org/pediatrics/article/154/2/e2024066842/197803/Health-Supervision-for-Children-and-Adolescents?autologincheck=redirected
http://www.ncbi.nlm.nih.gov/pubmed/39034826?tool=bestpractice.com
Advise patients on appropriate methods of contraception, such as progesterone-only contraceptive implants and pills, and levonorgestrel intrauterine devices. Combined hormonal contraceptives are not recommended because they may increase the risk of thromboembolic disease. Injectable progesterone-only contraceptives (depot medroxyprogesterone acetate) are associated with risk of venous thrombosis. Copper intrauterine devices are not usually recommended due to concern that risk of blood loss may be increased.[151]Nguyen AT, Curtis KM, Tepper NK, et al. U.S. Medical eligibility criteria for contraceptive use, 2024. MMWR Recomm Rep. 2024 Aug 8;73(4):1-126.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11315372
http://www.ncbi.nlm.nih.gov/pubmed/39106314?tool=bestpractice.com
[152]Leroy-Melamed M, McGann P, Van Doren L. How we approach contraception for adolescents and young adults with sickle cell disease. Pediatr Blood Cancer. 2025 Jun;72(6):e31683.
http://www.ncbi.nlm.nih.gov/pubmed/40134115?tool=bestpractice.com